[Liver transplantation].
Liver transplantation has developed as standard therapy for end-stage liver disease and fulminant hepatic failure with excellent results. The application of new techniques including split liver and living donor liver transplantation (LDLT) has only marginally increased the total number of liver transplants. The experience in children however has proven that short and long-term survival can be achieved with LDLT. Currently, the widening gap between waiting lists and organ supply is the major limiting factor resulting in increasing waiting times and death on the waiting list affecting up to 20% of patients.
Steurer
W
W
Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum Tübingen. wolfgang.steurer@med.uni-tuebingen.de
D000328:Adult; D002648:Child; D005060:Europe; D006801:Humans; D008107:Liver Diseases / Q000401:mortality / Q000601:surgery*; D017093:Liver Failure / Q000401:mortality / Q000601:surgery*; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods / Q000639:trends; D019520:Living Donors; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D015996:Survival Rate; D014019:Tissue Donors / Q000600:supply & distribution; D014850:Waiting Lists